Which members of Congress have traded EBS?

1 member of Congress has disclosed 2 trade in Emergent BioSolutions Inc. (EBS) under the STOCK Act: Josh Gottheimer.

When was EBS most recently disclosed by Congress?

The most recent EBS disclosure was a purchase by Josh Gottheimer on 18 October 2021.

What is the total disclosed congressional trading volume for EBS?

Members of Congress have disclosed approximately $8K in EBS purchases and $8K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.

How can I track new congressional trades in EBS?

This EBS page updates as soon as new STOCK Act disclosures are filed for Emergent BioSolutions Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.

Emergent BioSolutions Inc. (EBS)

NYSE • Currently up 0.24 (+3.00%) in today's trading session

1 member of Congress has disclosed 2 trades in Emergent BioSolutions Inc. (EBS) via STOCK Act filings. The most recent disclosure was a purchase by Josh Gottheimer on 18 October 2021. Aggregate disclosed activity totals roughly $8K in purchases and $8K in sales (midpoint estimates from bracketed disclosure amounts).

Emergent BioSolutions Inc. is currently trading at $8.23, positioned at 38% of its 52-week range ($4.71 – $14.06).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only

Copy Portfolio Claim Free Asset

Live portfolio tracking

Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price

$8.23

24h Change

+0.24 (+3.00%)

52 Week Range

$4.71—$14.06

View on NASDAQ

Emergent BioSolutions Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for EBS

Select to highlight on chart

Politician

2 transactions

Include Non-Compliant

Compliance: 100%


	Josh Gottheimer	18 Oct 2021	15 Nov 2021	Purchase	Stock	$1,001 - $15,000	N/A
	Josh Gottheimer	15 Sept 2021	13 Oct 2021	Sale	Stock	$1,001 - $15,000	N/A

Select transactions to view their annotations on the chart

Earnings

Next Report

Q1 2026

30 Apr

EPS Est.

$-0.25

Rev. Est.

$145M

Days Until

Recent Quarters

Q4 202526 Feb

EPS$-0.43

Miss 490.9%

Q3 202529 Oct

EPS$1.06

Beat 983.3%

Q2 20256 Aug

EPS$0.16

Beat 161.5%

Q1 20257 May

EPS$0.71

Beat 44.9%

Q4 20243 Mar

EPS$0.05

Beat 114.3%

Q3 20246 Nov

EPS$1.37

Beat 179.6%

Q2 20246 Aug

EPS$-2.32

Miss 139.2%

Q1 20241 May

EPS$0.59

Beat 168.6%

Q4 20236 Mar

EPS$-0.77

Miss 133.3%

Q3 202311 Dec

EPS$-1.76

Q3 202311 Dec

EPS$-1.44

Miss 1100.0%

Q2 20238 Aug

EPS$-1.06

Miss 8.2%

Q2 20238 Aug

EPS$-5.15

Q1 20239 May

EPS$-3.17

Miss 89.8%

Q4 202227 Feb

EPS$-1.76

Q3 20228 Nov

EPS$-1.27

Miss 2016.7%

Q2 20221 Aug

EPS$-0.86

Miss 236.5%

Q1 202228 Apr

EPS$0.18

Miss 25.0%

Q1 202228 Apr

EPS$-0.07

Q4 202124 Feb

EPS$4.50

Beat 5.4%

Q3 20214 Nov

EPS$-0.36

Miss 117.7%

Q3 20214 Nov

EPS$-0.65

Q2 202129 Jul

EPS$0.33

Miss 81.8%

Q1 202129 Apr

EPS$1.53

Beat 36.6%

Q4 202018 Feb

EPS$3.67

Beat 15.1%

Q3 20205 Nov

EPS$2.19

Beat 6.8%

Q2 202030 Jul

EPS$1.98

Beat 191.2%

Q1 202030 Apr

EPS$0.01

Beat 150.0%

Q4 201920 Feb

EPS$1.57

Miss 6.0%

Q3 20196 Nov

EPS$1.21

Beat 92.1%

Q2 20191 Aug

EPS$0.12

Miss 25.0%

Q1 20192 May

EPS$-0.13

Miss 200.0%

Q4 201821 Feb

EPS$0.75

Beat 22.9%

Q3 20181 Nov

EPS$0.55

Miss 11.3%

Q2 20182 Aug

EPS$1.07

Beat 21.6%

Q1 20183 May

EPS$-0.03

Miss 110.0%

Q4 201722 Feb

EPS$0.74

Beat 5.7%

Q3 20172 Nov

EPS$0.73

Beat 78.0%

Q2 20173 Aug

EPS$0.13

Miss 50.0%

Q1 20174 May

EPS$0.29

Miss 3.3%

Q4 201623 Feb

EPS$0.74

Beat 54.2%

Q3 20167 Nov

EPS$0.58

Beat 123.1%

Q2 20164 Aug

EPS$-0.18

Beat 21.7%

Q1 20165 May

EPS$0.16

Beat 260.0%

Q4 201525 Feb

EPS$0.78

Beat 11.4%

Q3 20155 Nov

EPS$0.83

Beat 50.9%

Q2 20156 Aug

EPS$0.36

Beat 100.0%

Q1 20157 May

EPS$-0.50

Miss 8.7%

Q4 20145 Mar

EPS$0.75

Beat 8.7%

Q4 201423 Jan

EPS$0.47

Q2 20147 Aug

EPS$0.24

Miss 7.7%

Q1 20148 May

EPS$-0.40

Miss 185.7%

Q4 20136 Mar

EPS$0.41

Beat 13.9%

Q3 20137 Nov

EPS$0.36

Beat 71.4%

Q2 20135 Aug

EPS$0.29

Beat 38.1%

Q1 20132 May

EPS$-0.22

Miss 144.4%

Q4 20127 Mar

EPS$0.44

Miss 2.2%

Q3 20121 Nov

EPS$0.18

Beat 28.6%

Q2 20122 Aug

EPS$0.21

Miss 8.7%

Q1 20123 May

EPS$-0.02

Beat 86.7%

Q4 20118 Mar

EPS$0.78

Beat 8.3%

Q3 20113 Nov

EPS$0.04

Miss 60.0%

Q2 20114 Aug

EPS$0.39

Beat 14.7%

Q1 20115 May

EPS$-0.61

Miss 17.3%

Q4 201010 Mar

EPS$0.76

Beat 13.4%

Q3 20104 Nov

EPS$0.41

Miss 21.1%

Q2 20105 Aug

EPS$0.31

Beat 19.2%

Q1 20105 May

EPS$0.08

Miss 52.9%

Q4 20094 Mar

EPS$0.13

Beat 160.0%

Q3 20095 Nov

EPS$0.03

Miss 50.0%

Q2 20096 Aug

EPS$0.48

Beat 60.0%

Q1 20097 May

EPS$0.35

Beat 169.2%

Q4 20085 Mar

EPS$0.05

Beat 150.0%

Q3 20086 Nov

EPS$0.34

Beat 88.9%

Q2 20087 Aug

EPS$0.06

Miss 73.9%

Q1 20087 May

EPS$0.24

Miss 11.1%

Q4 20077 Mar

EPS$0.93

Beat 6.9%

Q3 20072 Nov

EPS$0.10

Beat 475.0%

Q2 20076 Aug

EPS$-0.17

Beat 32.0%

Q1 20079 May

EPS$-0.10

Miss 599.8%

Q4 200622 Mar

EPS$1.03

Beat 30.4%

Q2 200630 Sept

EPS$-0.05

Q1 200630 Jun

EPS$-0.05

Q4 200531 Mar

EPS$-0.05

Q3 200531 Dec

EPS$0.38

Q2 200530 Sept

EPS$0.09

Q1 200530 Jun

EPS$0.09

Q4 200431 Mar

EPS$0.09

Q3 200431 Dec

EPS$0.14

Q2 200430 Sept

EPS$0.14

Q1 200430 Jun

EPS$0.14

Q4 200331 Mar

EPS$0.14

Q3 200031 Dec

EPS$-1.74

1 politician traded within 30 days

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

No similar stocks found

No congressional trading patterns available for recommendations

Frequently Asked Questions about EBS

Which members of Congress have traded EBS?: 1 member of Congress has disclosed 2 trade in Emergent BioSolutions Inc. (EBS) under the STOCK Act: Josh Gottheimer.
When was EBS most recently disclosed by Congress?: The most recent EBS disclosure was a purchase by Josh Gottheimer on 18 October 2021.
What is the total disclosed congressional trading volume for EBS?: Members of Congress have disclosed approximately $8K in EBS purchases and $8K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in EBS?: This EBS page updates as soon as new STOCK Act disclosures are filed for Emergent BioSolutions Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.

Emergent BioSolutions Inc. (EBS)

Want to automatically copy Pelosi trades?

Emergent BioSolutions Inc. Price History and Technical Analysis

Congressional Trading Activity for EBS

Stock Overview

Market Data

Fundamentals

Company Information

Earnings

Next Report

Recent Quarters

Similar Stocks

Frequently Asked Questions about EBS

Emergent BioSolutions Inc. (EBS)

Want to automatically copy Pelosi trades?

Emergent BioSolutions Inc. Price History and Technical Analysis

Congressional Trading Activity for EBS

Stock Overview

Market Data

Fundamentals

Company Information

Earnings

Next Report

Recent Quarters

Similar Stocks

Frequently Asked Questions about EBS

Track EBS in Congress